← back to search

Jiye Liu

Shandong First Medical University · CN
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Chromatin Remodeling and Cancer, and Multiple Myeloma Research and Treatments.
h-index
19
citations
1,471
works
178
NIH funding
primary concept
Multiple myeloma
email

Recent publications

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma
Nature Communications 2024cited by 34position: firstdoi
Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways
Leukemia 2020cited by 61position: middledoi
NTIRE 2020 Challenge on Real Image Denoising: Dataset, Methods and Results
2020cited by 12position: middledoi
NTIRE 2018 Challenge on Single Image Super-Resolution: Methods and Results
2018cited by 371position: middledoi
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
Leukemia 2018cited by 82position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Kenneth C. Anderson · Baptist Health Louisville3 papers (2018–2024)Teru Hideshima · Harvard University3 papers (2018–2024)Yu‐Tzu Tai · Cancer Research Center2 papers (2018–2024)Keiji Kurata · Cancer Clinic2 papers (2020–2024)Daisuke Ogiya · Dana-Farber Cancer Institute2 papers (2020–2024)Tianyu Song · Dalian University of Technology2 papers (2018–2024)Su Wang · China-Japan Friendship Hospital2 papers (2018–2024)Lijie Xing · Shandong University2 papers (2018–2024)Eugenio Morelli · University of Ferrara1 papers (2024–2024)Ruben D. Carrasco · Harvard University1 papers (2024–2024) · 1 papers (2020–2020)Paul G. Richardson · Harvard University1 papers (2024–2024)Nikhil C. Munshi · Harvard University1 papers (2024–2024)Yuntong Liu · Jilin University1 papers (2024–2024) · 1 papers (2020–2020) · 1 papers (2024–2024) · 1 papers (2024–2024)Yong Cang · ShanghaiTech University1 papers (2018–2018)Walter Massefski · Massachusetts Institute of Technology1 papers (2020–2020)Gongwei Wu · Guangzhou Medical University1 papers (2024–2024)